Lv51
894 积分 2025-08-25 加入
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families
1小时前
已关闭
Global trends in lung cancer incidence and mortality by age, gender and morphology and forecast: A bootstrap-based analysis
5小时前
已完结
Cancer treatment therapies: traditional to modern approaches to combat cancers
2个月前
已完结
Liposomes-enabled cancer chemoimmunotherapy
2个月前
已完结
Cancer treatment therapies: traditional to modern approaches to combat cancers
2个月前
已完结
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US
2个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
2个月前
已完结
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
2个月前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
2个月前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
